China-based biotech BeiGene (Nasdaq: BGNE; HKG: 6160; SHA: 688235) has announced the launch of a new mental health program focused on cancer patients. The “Talk About It: Cancer and Mental Health” program, which includes the website CancerandMentalHealth.com, is designed to ensure that mental health is considered a vital part of care for cancer patients.
Program Details
BeiGene cites data from a study it sponsored, carried out by the non-profit organization Cancer Support Community. According to the study, up to 25% of cancer patients also suffer from depression, while emotional distress and anxiety can occur at any stage of treatment and recovery. Patient surveys reveal that 60% of cancer sufferers are not referred to a mental health professional, and two in five patients who wanted or sought mental health support did not receive it.
Resources and Support
CancerandMentalHealth.com provides digital and printable resources for patients, caregivers, and healthcare professionals. The website focuses on the impact of a cancer diagnosis and offers links to resources from leading advocacy organizations, including support helplines, online communities, and local support groups. BeiGene aims to continue raising the level of mental health support for cancer sufferers as part of a holistic approach designed to improve both patient well-being and treatment outcomes.-Fineline Info & Tech
